A systematic approach for establishing humane endpoints.
about
Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cellsRespiratory transmission of an avian H3N8 influenza virus isolated from a harbour sealHuman H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism.Prevalence and characterization of influenza viruses in diverse species in Los Llanos, Colombia.Swine Influenza Virus (H1N2) Characterization and Transmission in Ferrets, ChileA protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infectionIncreased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutininExtracorporeal Life Support Increases Survival After Prolonged Ventricular Fibrillation Cardiac Arrest in the Rat.Identification of markers for imminent death in mice used in longevity and aging researchWelfare issues of genetically modified animals.Core body temperature as adjunct to endpoint determination in murine median lethal dose testing of rattlesnake venom.Possibilities for refinement and reduction: future improvements within regulatory testing.Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infectionNon-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccineInfluence of repeated anaesthesia on physiological parameters in male Wistar rats: a telemetric study about isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanylMarkers for predicting death as an outcome for mice used in infectious disease research.Using obese mouse models in research: special considerations for IACUC members, animal care technicians, and researchers.Health Evaluation of Experimental Laboratory MiceHock immunization: a humane alternative to mouse footpad injections.Predictive observation-based endpoint criteria for mice receiving total body irradiationEndpoints for mouse abdominal tumor models: refinement of current criteria.Avian H11 influenza virus isolated from domestic poultry in a Colombian live animal market.Assessing the fitness of distinct clades of influenza A (H9N2) viruses.Animal-based welfare monitoring: using keeper ratings as an assessment tool.Vascular Permeability Drives Susceptibility to Influenza Infection in a Murine Model of Sickle Cell Disease.A systematic process for physical examination in preclinical research.The upper limits of pain and suffering in animal research.Considerations for Infectious Disease Research Studies Using Animals.Opportunities to Apply the 3Rs in Safety Assessment Programs.Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models.Analgesia in clinically relevant rodent models of sepsis.Induction of experimental obstructive cholestasis in mice.Refinements in husbandry, care and common procedures for non-human primates: Ninth report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement.Institutional Animal Care and Use Committee Considerations Regarding the Use of Virus-Induced Carcinogenesis and Oncolytic Viral Models.A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.Endpoint refinement for total body irradiation of C57BL/6 mice.Chemotherapy-induced changes in cardiac capillary permeability measured by fluorescent multiple indicator dilution.Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model.
P2860
Q30151873-C6E9BD55-7BF9-4A9A-A90E-BDE2F5D82692Q30357092-8C28A083-E6FC-4806-8A36-19EA46A1BFB6Q30366374-4CF8A24F-8141-4404-856F-7B5A79D6A49BQ30366672-38FB1F5F-DA73-4FDC-B021-74870F20526FQ30375247-16597FEE-431D-41B1-85B6-AB799C98523AQ30397642-FF4D294C-57F3-4C2C-BE30-53168E8A1952Q30400787-B0E346D7-8A5A-484B-BFC3-963F59FC2A5BQ30407072-45D9F48C-9C97-4B77-B3DD-EFEECEA74ED3Q30491829-8E9648EF-DA03-4C2B-BE24-76080521DDE1Q33880081-527F6ED3-2E33-422E-A963-B25ACD6D64A4Q34578774-CCB8A1EC-11BD-4E65-BB1D-A8662C953B6BQ34764080-4547EED8-81CE-4E6C-9493-32C9539DE273Q34975176-85230485-9219-42AE-AC4D-52868DF96DA6Q35193034-4C6BB2D6-D360-492B-8E01-BC23FEA01E29Q35217259-6926F3B4-B72B-4F6F-B9A5-A654A24DA814Q35301495-95346827-FC8B-44BD-8022-675097D032C7Q35536147-46A807F9-1617-4F05-8965-26C96BF68B50Q35609865-93752D94-EF63-43DE-B927-86B0C1EACF5DQ36026746-CA6DED88-57E8-4246-A45D-7FD5D426A198Q36102497-351F0C47-821A-42F5-A1E8-493BB69860DEQ36766183-B188972D-5D08-4BB3-B658-D417FC9BC080Q37113805-8FF9743F-128C-40F3-AD5B-2A8987842254Q37322375-6233F9C3-02C0-46B4-ADFD-CBE05A903E51Q37529510-BB25A0FB-12E3-4D4E-A9D1-1DCDD141AE7AQ37584347-6084CBB2-7C0B-4716-9568-B82363A55B2CQ37620265-CA36197B-36E8-48A1-8871-A91DF647B66BQ37679060-0AFB66CE-3A4F-4FD5-A14E-FDCA55BFD940Q38360483-D6825725-398A-47C1-8BBC-165EDC19EC38Q38585896-B27D87C4-62AF-4321-B976-03ED134544FBQ38701962-8523F1C1-91A4-4A82-96B1-2DC889B81D5BQ38774773-D5CE52DB-B47A-406C-9745-3018CC1C3E0EQ38957233-2794DA11-3200-41F1-9BB6-9879A7712E91Q39026500-50F6CDFF-53E1-4A76-BA42-596914489515Q39191568-9298A7B6-921C-490E-BF79-3264F7B6C164Q39228016-10B1632A-D0CE-4123-9A50-E9173263AAABQ40823356-09DE4671-984B-4DC9-A369-98E67ACAFCC5Q41676300-BE6AA5E1-F481-4283-B7B0-0F5F0C87B982Q42154414-D8C0EA62-F338-40BD-A10A-498E4E3A1D98Q42550655-79679D59-A522-4734-B0DF-5CE041859CFDQ46279362-81ABDFC1-D0E7-4307-B7CE-4AB42024AB69
P2860
A systematic approach for establishing humane endpoints.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A systematic approach for establishing humane endpoints.
@ast
A systematic approach for establishing humane endpoints.
@en
A systematic approach for establishing humane endpoints.
@nl
type
label
A systematic approach for establishing humane endpoints.
@ast
A systematic approach for establishing humane endpoints.
@en
A systematic approach for establishing humane endpoints.
@nl
prefLabel
A systematic approach for establishing humane endpoints.
@ast
A systematic approach for establishing humane endpoints.
@en
A systematic approach for establishing humane endpoints.
@nl
P2860
P356
P1433
P1476
A systematic approach for establishing humane endpoints.
@en
P2093
D B Morton
P2860
P356
10.1093/ILAR.41.2.80
P577
2000-01-01T00:00:00Z